Table 3.
Distribution of key variables in cases and controls (non diabetic) in epithelial ovarian cancer (EOC cohort). Comparison is also made with the diabetic control group.
| Variable | Cases n(%) |
Controls n(%) |
Diabetic controls€ € n(%) |
p | |
|---|---|---|---|---|---|
| Total | 61(100) | 178(100) | 103 (100) | ||
| Age (years)* | Mean€ | 62(SD=11)* | 61(SD=11)* | 65(SD=13) | 0.06 |
| Body Mass Index (BMI) | Mean€ | 34 (SD=7) | 28 (SD=6) | 30 (8) | <0.001 |
| FIGO Stage* | I | 15(25)* | 43(24)* | 16 (17) | 0.7 |
| II | 5(8)* | 13(7)* | 5 (5) | ||
| III | 35(57)* | 105(59)* | 59 (63) | ||
| IV | 6(10)* | 17(10)* | 13 (14) | ||
| Grade | High | 45(74) | 141(79) | 81 (80) | 0.6 |
| Low | 16(26) | 37(21) | 20 (20) | ||
| Histology | Serous | 39(64) | 126(71) | 78 (76) | 0.2 |
| Non-Serous | 22(36) | 52(29) | 25 (24) | ||
| Optimal Cytoreduction* | Yes | 49(80)* | 146(82)* | 80 (78) | 0.2 |
| No | 11(18)* | 30(17)* | 21 (20) | ||
| Unknown | 1(2) | 2(1) | 2 (2) | ||
| Chemotherapy** | Platinum based | 49(86) | 152(88) | 74 (83) | 0.3 |
| Non-Platinum | 0(0) | 5(3) | 2 (2) | ||
| None | 8(14) | 15(9) | 13 (15) |
*
Matching variable
**
Unknown for 10 patients
€
SD=Standard deviation
€ €
Matching with cases not possible due to small sample size in the diabetic control group. In the diabetic control group, FIGO stage was unknown for 10, grade unknown for 2 and chemotherapy was unknown for 14 patients.